The trademark application was filed by Esperion Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on April 21, 2020, and it was registered by office on July 30, 2020 without any oppositions.
The application was filed in English (French was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on November 24, 2020.